Literature DB >> 15481311

Analysis of pancreatic elastase-1 concentrations in duodenal aspirates from healthy subjects and patients with chronic pancreatitis.

Tyler Stevens1, Darwin Conwell, Gregory Zuccaro, Frederick Van Lente, Farah Khandwala, Patrick Hanaway, John J Vargo, John A Dumot.   

Abstract

Fecal pancreatic elastase 1 (PE-1) has been advocated as a noninvasive marker of pancreatic function and allows detection of moderate and severe exocrine insufficiency. Few studies have evaluated the utility of measuring PE-1 in duodenal fluid for the diagnosis of pancreatic insufficiency. Our purpose was (1) to determine the feasibility of measuring PE-1 concentrations in duodenal aspirates obtained through our endoscopic pancreatic function test (ePFT) in healthy subjects and patients with chronic pancreatitis (CP) and (2) to determine correlations between duodenal PE-1 concentrations and bicarbonate and lipase concentrations in duodenal fluid. Healthy subjects (HS) and CP patients underwent an ePFT with CCK or secretin. CP was defined as endoscopic retrograde pancreatography (ERP) Cambridge class III-IV, endoscopic ultrasound (EUS) score >5, or presence of pancreatic calcifications on CT scan. Duodenal fluid PE-1, lipase, and bicarbonate concentrations were measured in each study group. Duodenal lipase and bicarbonate concentrations were measured using an autoanalyzer (Roche Diagnostics, Indianapolis, IN). PE-1 was measured using an ELISA (Genova Diagnostics, Asheville, NC). Ten HS and 10 CP patients were studied. In the CCK test the median peak lipase for HS and CP was 1605 and 113 IU/L, respectively (P < 0.008). In the secretin test the median peak bicarbonate for HS and CP was 102 and 40 mEq/L, respectively (p < 0.008). Median PE-1 concentrations for HS and CP were 317 and 63 microg/ml, respectively, after CCK stimulation (p = 0.046) and 87 and 17 microg/ml, respectively, after secretin stimulation (p = 0.033). Statistically significant correlations were found between [PE-1] and peak [lipase] (r = 0.83, P < 0.001), as well as [PE-1] and peak [HCO3(3)-] (r = 0.65, P = 0.037). Conclusions are as follows: (1) PE-1 concentrations can be measured from duodenal fluid obtained by endoscopic aspiration. (2) Duodenal fluid PE-1 concentrations are decreased in CP compared to HS. (3) Duodenal fluid [PE-1] has an excellent correlation with [lipase] and therefore is a marker of acinar cell function. (4) Secretin-stimulated endoscopic function testing with measurement of bicarbonate and PE-1 may provide a simultaneous assessment of both ductal cell and acinar cell function.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15481311     DOI: 10.1023/b:ddas.0000042238.80040.cc

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  32 in total

1.  Value of combinations of pancreatic function tests to predict mild or moderate chronic pancreatitis.

Authors:  U Gunkel; N Bitterlich; V Keim
Journal:  Z Gastroenterol       Date:  2001-03       Impact factor: 2.000

2.  Studies in pancreatic function; preliminary series of clinical studies with the secretin test.

Authors:  D A DREILING; F HOLLANDER
Journal:  Gastroenterology       Date:  1948-11       Impact factor: 22.682

3.  Classification of pancreatitis.

Authors:  M Sarner; P B Cotton
Journal:  Gut       Date:  1984-07       Impact factor: 23.059

4.  Comparison of two tubeless function tests in the assessment of mild-to-moderate exocrine pancreatic insufficiency.

Authors:  A Leodolter; S Kahl; J E Domínguez-Muñoz; C Gerards; B Glasbrenner; P Malfertheiner
Journal:  Eur J Gastroenterol Hepatol       Date:  2000-12       Impact factor: 2.566

5.  Prospective assessment of the ability of endoscopic ultrasound to diagnose, exclude, or establish the severity of chronic pancreatitis found by endoscopic retrograde cholangiopancreatography.

Authors:  A V Sahai; M Zimmerman; L Aabakken; P R Tarnasky; J T Cunningham; A van Velse; R H Hawes; B J Hoffman
Journal:  Gastrointest Endosc       Date:  1998-07       Impact factor: 9.427

6.  Exocrine pancreatic function in correlation to ductal and parenchymal morphology in chronic pancreatitis.

Authors:  P Malfertheiner; M Büchler; A Stanescu; H Ditschuneit
Journal:  Hepatogastroenterology       Date:  1986-06

7.  An endoscopic pancreatic function test with synthetic porcine secretin for the evaluation of chronic abdominal pain and suspected chronic pancreatitis.

Authors:  Darwin L Conwell; Gregory Zuccaro; John J Vargo; Patricia A Trolli; Frederick Vanlente; Nancy Obuchowski; John A Dumot; Cathy O'laughlin
Journal:  Gastrointest Endosc       Date:  2003-01       Impact factor: 9.427

8.  Structure and function in noncalcific pancreatitis.

Authors:  A H Girdwood; A R Hatfield; P C Bornman; M E Denyer; R E Kottler; I N Marks
Journal:  Dig Dis Sci       Date:  1984-08       Impact factor: 3.199

9.  Immunoreactive elastase I: clinical evaluation of a new noninvasive test of pancreatic function.

Authors:  J Stein; M Jung; A Sziegoleit; S Zeuzem; W F Caspary; B Lembcke
Journal:  Clin Chem       Date:  1996-02       Impact factor: 8.327

10.  Studies on the sterol-binding capacity of human pancreatic elastase 1.

Authors:  A Sziegoleit; D Linder
Journal:  Gastroenterology       Date:  1991-03       Impact factor: 22.682

View more
  10 in total

1.  Fecal elastase: a useful test for pancreatic insufficiency?

Authors:  Jo Tod; David Fine
Journal:  Dig Dis Sci       Date:  2010-10       Impact factor: 3.199

Review 2.  Endoscopy-based pancreatic function tests.

Authors:  Surakit Pungpapong; Massimo Raimondo
Journal:  Curr Gastroenterol Rep       Date:  2006-04

3.  Cytokine profiling of pancreatic fluid using the ePFT collection method in tandem with a multiplexed microarray assay.

Authors:  Joao A Paulo; Linda S Lee; Bechien Wu; Peter A Banks; Hanno Steen; Darwin L Conwell
Journal:  J Immunol Methods       Date:  2011-05-01       Impact factor: 2.303

4.  Proteomic analysis (GeLC-MS/MS) of ePFT-collected pancreatic fluid in chronic pancreatitis.

Authors:  Joao A Paulo; Vivek Kadiyala; Linda S Lee; Peter A Banks; Darwin L Conwell; Hanno Steen
Journal:  J Proteome Res       Date:  2012-02-07       Impact factor: 4.466

Review 5.  Mass spectrometry-based proteomics of endoscopically collected pancreatic fluid in chronic pancreatitis research.

Authors:  Joao A Paulo; Linda S Lee; Bechien Wu; Peter A Banks; Hanno Steen; Darwin L Conwell
Journal:  Proteomics Clin Appl       Date:  2011-03-01       Impact factor: 3.494

6.  Identification of pancreas-specific proteins in endoscopically (endoscopic pancreatic function test) collected pancreatic fluid with liquid chromatography--tandem mass spectrometry.

Authors:  Joao A Paulo; Linda S Lee; Bechien Wu; Kathryn Repas; Koenraad J Mortele; Peter A Banks; Hanno Steen; Darwin L Conwell
Journal:  Pancreas       Date:  2010-08       Impact factor: 3.327

7.  Optimized sample preparation of endoscopic collected pancreatic fluid for SDS-PAGE analysis.

Authors:  Joao A Paulo; Linda S Lee; Bechien Wu; Kathryn Repas; Peter A Banks; Darwin L Conwell; Hanno Steen
Journal:  Electrophoresis       Date:  2010-07       Impact factor: 3.535

8.  Difference gel electrophoresis identifies differentially expressed proteins in endoscopically collected pancreatic fluid.

Authors:  Joao A Paulo; Linda S Lee; Peter A Banks; Hanno Steen; Darwin L Conwell
Journal:  Electrophoresis       Date:  2011-08       Impact factor: 3.535

9.  Analysis of endoscopic pancreatic function test (ePFT)-collected pancreatic fluid proteins precipitated via ultracentrifugation.

Authors:  Joao A Paulo; Vivek Kadiyala; Aleksandr Gaun; John F K Sauld; Ali Ghoulidi; Peter A Banks; Hanno Steen; Darwin L Conwell
Journal:  JOP       Date:  2013-03-10

10.  State of anxiety may be associated with exocrine pancreatic insufficiency in functional dyspepsia patients with pancreatic enzyme abnormalities.

Authors:  Shuhei Agawa; Seiji Futagami; Hiroshi Yamawaki; Katya Gudis; Kazutoshi Higuchi; Keiko Kaneko; Mayu Habiro; Yasuhiro Kodaka; Nobue Ueki; Yoshiyuki Watanabe; Norio Motoda; Ryuji Ohashi; Katsuhiko Iwakiri
Journal:  J Clin Biochem Nutr       Date:  2021-09-03       Impact factor: 3.114

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.